| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |